Protagonist Therapeutics, Inc. ($PTGX)
Filing Information
| Accession Number | 0001104659-26-007128 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 28, 2026 |
| Document Date | Jan 27, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
102,203
Total Value
$4,294,117.42
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Jan 27, 2026 | Exercise/Conversion | 16,000 | $19.19 | $307,040.00 | 94,523 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jan 27, 2026 | Exercise/Conversion | 12,000 | $12.17 | $146,040.00 | 106,523 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jan 27, 2026 | Sale | 28,000 | $83.13 | $2,327,640.00 | 78,523 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jan 27, 2026 | Sale | 18,203 | $83.14 | $1,513,397.42 | 60,320 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (right to buy) | Derivative | Jan 27, 2026 | Exercise/Conversion | 16,000 | $0.00 | $0.00 | 50,800 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (right to buy) | Derivative | Jan 27, 2026 | Exercise/Conversion | 12,000 | $0.00 | $0.00 | 18,547 | Direct | โ | View Details |